In this article we report our experience with CT-guided bone biopsy (CTGBB) using a new nondisposable bone biopsy device with in a uniform protocol for all lesions and compare our results with data from bone biopsies obtained with other techniques. With this biopsy device, the specimen is collected in a 20 x 2 mm chamber of an apple corer-shaped needle. In 46 consecutive @entity5 @entity1 that were candidates for bone biopsy, 50 CTGBB procedures were performed and analyzed. Lesions with @entity154 and/or surrounding soft tissue infiltration were excluded. There were no complications. Of 50 CTGBB procedures, 90% were diagnostic. Four of the five inconclusive biopsies were repeated: All were conclusive, one malignant. Of 19 with CT-indistinguishable lesions (detected on MRI or isotope studies), 35% were malignant. Thirty-eight percent of the lesions were not accompanied by @entity158 . The procedure was less @entity158 than injection of the local anesthetic prior to biopsy in 90% of the cases. With the new device, CTGBB procedures can be carried out safely. Biopsy with the described technique has a high diagnostic output, better results than those of biopsy with reported uniform techniques, and equal results to the best results of combined techniques. If a lesion is not distinguishable on CT and/or not accompanied by @entity158 , @entity5 is not ruled out. CTGBB in the described technique is less or equally time consuming, less @entity158 , and cheaper than reported for other bone biopsy procedures.

CT-guided bone biopsy in a XXXX center: experience with a new apple corer-shaped device.

@entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'malignancy'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity154 :: ('MESH:D000013', 'Disease') :: ['cortical defects'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'painful']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
